中华泌尿外科杂志
中華泌尿外科雜誌
중화비뇨외과잡지
CHINESE JOURNAL OF UROLOGY
2001年
1期
28-30
,共3页
夏庆华%许纯孝%尉立京%劳平%王春霞
夏慶華%許純孝%尉立京%勞平%王春霞
하경화%허순효%위립경%로평%왕춘하
膀胱肿瘤%癌%基因
膀胱腫瘤%癌%基因
방광종류%암%기인
目的 探讨Fas和Bcl-2在膀胱移行细胞癌的表达及其与膀胱癌生物学行为的关系。方法 应用免疫组化SABC法检测42例膀胱移行细胞癌标本中Fas和Bcl-2的表达情况,并与膀胱癌的病理分级、临床分期及随访结果相比较。结果 31例(73.8%)Fas表达阳性,23例(56.1%)Bcl-2表达阳性,低分化和晚期膀胱移行细胞癌中二者表达均增加。结论 Fas和Bcl-2表达可以作为监测膀胱移行细胞癌恶性程度、预测复发的重要指标。在低分化和晚期膀胱移行细胞癌中,Fas所介导的细胞凋亡可能被Bcl-2的过度表达所抑制。
目的 探討Fas和Bcl-2在膀胱移行細胞癌的錶達及其與膀胱癌生物學行為的關繫。方法 應用免疫組化SABC法檢測42例膀胱移行細胞癌標本中Fas和Bcl-2的錶達情況,併與膀胱癌的病理分級、臨床分期及隨訪結果相比較。結果 31例(73.8%)Fas錶達暘性,23例(56.1%)Bcl-2錶達暘性,低分化和晚期膀胱移行細胞癌中二者錶達均增加。結論 Fas和Bcl-2錶達可以作為鑑測膀胱移行細胞癌噁性程度、預測複髮的重要指標。在低分化和晚期膀胱移行細胞癌中,Fas所介導的細胞凋亡可能被Bcl-2的過度錶達所抑製。
목적 탐토Fas화Bcl-2재방광이행세포암적표체급기여방광암생물학행위적관계。방법 응용면역조화SABC법검측42례방광이행세포암표본중Fas화Bcl-2적표체정황,병여방광암적병리분급、림상분기급수방결과상비교。결과 31례(73.8%)Fas표체양성,23례(56.1%)Bcl-2표체양성,저분화화만기방광이행세포암중이자표체균증가。결론 Fas화Bcl-2표체가이작위감측방광이행세포암악성정도、예측복발적중요지표。재저분화화만기방광이행세포암중,Fas소개도적세포조망가능피Bcl-2적과도표체소억제。
Objective To investigate Fas and Bcl-2 gene expression and to evaluate their significance on the biological behavior of the tumor.Methods Fas and Bcl-2 gene expression were detected in 42 specimens by immunohistochemistry.Results 31(73.8%) cases were positive in Fas expression, while 23 (56.1%) cases were positive in Bcl-2 expression. The expression of Fas and Bcl-2 increased in bladder neoplasms of low differentiation and late stages.Conclusions The expression of Fas and Bcl-2 might have a practical significance in assessing the malignancy and recurrence. Overexpression of Bcl-2 in bladder transitional cell carcinoma resulted in a partial inhibition of Fas-induced cell death.